Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India

Abstract

BackgroundVisceral leishmaniasis (VL) has been targeted by the WHO for elimination as a public health problem (< 1 case/10,000 people/year) in the Indian sub-continent (ISC) by 2020. Bihar State in India, which accounts for the majority of cases in the ISC, remains a major target for this elimination effort. However, there is considerable spatial, temporal and sub-population variation in occurrence of the disease and the pathway to care, which is largely unexplored and a threat to achieving the target.MethodsData from 6081 suspected VL patients who reported being clinically diagnosed during 2012–2013 across eight districts in Bihar were analysed. Graphical comparisons and Chi-square tests were used to determine differences in the burden of identified cases by season, district, age and sex. Log-linear regression models were fitted to onset (of symptoms)-to-diagnosis and onset-to-treatment waiting times to estimate their associations with age, sex, district and various socio-economic factors (SEFs). Logistic regression models were used to identify factors associated with mortality.ResultsComparisons of VL caseloads suggested an annual cycle peaking in January-March. A 17-fold variation in the burden of identified cases across districts and under-representation of young children (0–5 years) relative to age-specific populations in Bihar were observed. Women accounted for a significantly lower proportion of the reported cases than men (41 vs 59%, P < 0.0001). Age, district of residence, house wall materials, caste, treatment cost, travelling for diagnosis and the number of treatments for symptoms before diagnosis were identified as correlates of waiting times. Mortality was associated with age, district of residence, onset-to-treatment waiting time, treatment duration, cattle ownership and cost of diagnosis.ConclusionsThe distribution of VL in Bihar is highly heterogeneous, and reported caseloads and associated mortality vary significantly across different districts, posing different challenges to the elimination campaign. Socio-economic factors are important correlates of these differences, suggesting that elimination will require tailoring to population and sub-population circumstances.Electronic supplementary materialThe online version of this article (10.1186/s13071-017-2530-9) contains supplementary material, which is available to authorized users.

Determinant Factors and Spatial Distribution of Visceral Leishmaniasis in North Gondar in Selected Hospitals

“…The finding of this study revealed that males VL patients accounted a larger (93.2%) proportion compared to female VL patients (6.8%). This result also supported by Sarah, et al [7]; Perry, et al [8].…”

NTD Diagnostics for Disease Elimination: A Review

“…This is the experience of the Guinea-worm and poliomyelitis campaigns [19], as well as the context behind Dowdle and Cochi's summation that "all eradication is ultimately local" [20] (p. 3). The central importance attached to diagnosis, as a means by which one might hope to understand and manage local settings, is now a key message coming out of the literature [21][22][23]. In this view, diagnostics and the data they yield promise to become a missing piece in the puzzle of disease elimination.…”

The potential impact of human visceral leishmaniasis vaccines on population incidence

“…There are two model variants, that only differ based on assumptions about where the main reservoir of infection lies; namely, solely in symptomatic individuals (VL and PKDL), or mainly in asymptomatic individuals [21,35,36]. The models were parameterized with age-structured data on approximately 21,000 individuals included in the KalaNet bednet trial in India and Nepal [37] and have undergone geographical cross-validation against data on >5000 VL cases from 8 endemic districts in Bihar collected by CARE India [38] (see [36] In the alternative model variant, asymptomatic individuals are assumed not to be infectious towards to sand fly, with infection pressure only coming from symptomatic individuals with VL (with and without treatment) and PKDL. Once a susceptible individual is infected by an infectious sand fly, they become early asymptomatic for an average duration of about 200 days, which is followed by the late asymptomatic stage (average duration of 69 days).…”